Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Covington
Federal Trade Commission
US Department of Justice
Boehringer Ingelheim
Cipla

Generated: June 25, 2019

DrugPatentWatch Database Preview

Litigation Details for ACTELION PHARMACEUTICALS LTD. v. KAPPOS (D.C. 2010)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in ACTELION PHARMACEUTICALS LTD. v. KAPPOS
The small molecule drug covered by the patent cited in this case is ➤ Sign Up .

Details for ACTELION PHARMACEUTICALS LTD. v. KAPPOS (D.C. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-07-06 1 by the assignee of United States Patent No. 7,094,781 (“the ‘781 Patent,” attached as Exhibit A), pursuant…11. The Director issued United States Patent No. 7,094,781 on August 22, 2006, thus exceeding 3-year…fully set forth. 19. United States Patent No. 7,094,781, assigned to Plaintiff, issued May 27, 2003…judgment that the patent term adjustment for the ‘781 Patent be 361 days, whereby the ‘781 patent will expire…of the patent term adjustment for the ‘781 Patent to 361 days, whereby the ‘781 Patent expires External link to document
2013-09-23 15 pharmaceutical company, holds U.S. Patent No. 7,094,781 (the “‘781 Patent”). Compl. [Dkt. # 1] 1111 3, 9.…BACKGROUND Patents are issued by USPTO for a term ending 20 years from the date the patent application… the patent is issued. 35 U.S.C. § 154(a)(2). As a result, delays by USPTO in examining a patent application…USPTO issues the patent and determines the final P'l`A as of the date of the patent grant, noting this…of a patent more than three years later. If USPTO took longer than three years to issue a patent, therefore External link to document
2010-11-01 4 the inventors on the face of U.S. Patent 7,094,781 (“‘781 patent”), entitled “Sulfamides and Their use…‘781 patent issued with a patent term adjustment of 312 days appearing on the face of the patent. Defendant…‘781 patent issued with a patent term adjustment of 312 days appearing on the face of the patent. Defendant…paragraph and avers that the ‘781 patent issued on August 22, 2006 with a patent term adjustment of 312 days…Property and Director of the ) United States Patent and Trademark Office, ) External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Federal Trade Commission
Farmers Insurance
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.